Angiostatin endostatin gene therapy - Genetix Pharmaceuticals
Alternative Names: GenostatinLatest Information Update: 08 Jul 2003
At a glance
- Originator Genetix Pharmaceuticals
- Class Gene therapies
- Mechanism of Action Angiogenesis inhibitors; Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 08 Jul 2003 Discontinued - Preclinical for Cancer in USA (Parenteral)
- 07 Jan 2002 No-Development-Reported for Cancer in USA (Parenteral)
- 21 Apr 1998 Preclinical development for Cancer in USA (Parenteral)